Molecular diagnosis of human prion disease

Bibliography

• Kovacs GG, Budka H. Molecular pathology of human prion diseases. Int J Mol Sci 2009;10:976-99
   PubMed Web of Science ®Google Scholar
• WHO. WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. Geneva: WHO, 2003
   Google Scholar
• Budka H, Aguzzi A, Brown P, Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:459-66
   PubMed Web of Science ®Google Scholar
• Ghetti B, Piccardo P, Frangione B, Prion protein amyloidosis. Brain Pathol 1996;6:127-45
   PubMed Web of Science ®Google Scholar
• Gambetti P, Dong Z, Yuan J, A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008;63:697-708
   PubMed Web of Science ®Google Scholar
• Zou WQ, Puoti G, Xiao X, Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010;68:162-72
   PubMed Web of Science ®Google Scholar
• Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003;66:255-65
   PubMed Web of Science ®Google Scholar
• Medori R, Tritschler HJ, LeBlanc A, Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992;326:444-9
   PubMed Web of Science ®Google Scholar
• Ghetti B, Bugiani O, Tagliavini F, Piccardo P. Gerstmann-Straussler-Scheinker disease. In: Dickson DW, editor. Neurodegeneration: The molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press 2003
   Google Scholar
• Kovacs GG, Trabattoni G, Hainfellner JA, Mutations of the prion protein gene phenotypic spectrum. J Neurol 2002;249:1567-82
   PubMed Web of Science ®Google Scholar
• Beck JA, Mead S, Campbell TA, Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 2001;57:354-6
   PubMed Web of Science ®Google Scholar
• Capellari S, Parchi P, Wolff BD, Creutzfeldt-Jakob disease associated with a deletion of two repeats in the prion protein gene. Neurology 2002;59:1628-30
   PubMed Web of Science ®Google Scholar
• Bruce ME, Fraser H. Scrapie strain variation and its implications. Curr Top Microbiol Immunol 1991;172:125-38
   PubMedGoogle Scholar
• Collinge J, Sidle KC, Meads J, Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 1996;383:685-90
   PubMed Web of Science ®Google Scholar
• Head MW, Bunn TJ, Bishop MT, Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004;55:851-9
   PubMed Web of Science ®Google Scholar
• Kascsak RJ, Rubenstein R, Merz PA, Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 1986;59:676-83
   PubMed Web of Science ®Google Scholar
• Parchi P, Capellari S, Chen SG, Typing prion isoforms. Nature 1997;386:232-4
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Capellari S, Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-78
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998;4:1157-65
   PubMed Web of Science ®Google Scholar
• Hill AF, Joiner S, Wadsworth JD, Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003;126:1333-46
   PubMed Web of Science ®Google Scholar
• Gambetti P, Kong Q, Zou W, Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003;66:213-39
   PubMed Web of Science ®Google Scholar
• Ironside JW, Ritchie DL, Head MW. Phenotypic variability in human prion diseases. Neuropathol Appl Neurobiol 2005;31:565-79
   Google Scholar
• Kovacs GG, Seguin J, Quadrio I, Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 2011;121:39-57
   PubMed Web of Science ®Google Scholar
• Monari L, Chen SG, Brown P, Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994;91:2839-42
   PubMed Web of Science ®Google Scholar
• Hill AF, Joiner S, Beck JA, Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 2006;129:676-85
   PubMedGoogle Scholar
• Parchi P, Zou W, Wang W, Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 2000;97:10168-72
   PubMed Web of Science ®Google Scholar
• Mead S. Prion disease genetics. Eur J Hum Genet 2006;14:273-81
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Hill AF, Joiner S, Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1999;1:55-9
   PubMed Web of Science ®Google Scholar
• Cali I, Castellani R, Yuan J, Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 2006;129:2266-77
   PubMed Web of Science ®Google Scholar
• Notari S, Capellari S, Giese A, Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 2004;279:16797-804
   PubMed Web of Science ®Google Scholar
• Zanusso G, Farinazzo A, Fiorini M, pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease. J Biol Chem 2001;276:40377-80
   PubMed Web of Science ®Google Scholar
• Parchi P, Notari S, Weber P, Inter-laboratory assessment of PrP(Sc) typing in Creutzfeldt-Jakob disease: a western blot study within the neuroprion consortium. Brain Pathol 2009;19:384-91
   PubMed Web of Science ®Google Scholar
• Cali I, Castellani R, Alshekhlee A, Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009;132:2643-58
   PubMedGoogle Scholar
• Puoti G, Giaccone G, Rossi G, Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 1999;53:2173-6
   PubMed Web of Science ®Google Scholar
• Schoch G, Seeger H, Bogousslavsky J, Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 2006;3:e14
   PubMed Web of Science ®Google Scholar
• Uro-Coste E, Cassard H, Simon S, Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 2008;4:e1000029
   PubMed Web of Science ®Google Scholar
• Parchi P, Strammiello R, Notari S, Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009;118:659-71
   PubMed Web of Science ®Google Scholar
• Head MW, Knight R, Zeidler M, A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009;35:628-32
   Google Scholar
• Jansen C, Head MW, van Gool WA, The first case of protease-sensitive prionopathy (PSPr) in the Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry 2010;81:1052-5
   PubMed Web of Science ®Google Scholar
• Rodriguez AB, Garrido JM, Zarranz JJ, A novel variant of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report. BMC Neurol 2010;10:99
   PubMedGoogle Scholar
• Ugnon-Cafe S, Dorey A, Bilheude JM, Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease. J Virol Methods 2011; In press
   Google Scholar
• Grassi J, Maillet S, Simon S, Morel N. Progress and limits of TSE diagnostic tools. Vet Res 2008;39:33
   PubMed Web of Science ®Google Scholar
• Meyer RK, McKinley MP, Bowman KA, Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 1986;83:2310-14
   PubMed Web of Science ®Google Scholar
• Brown P, Coker-Vann M, Pomeroy K, Diagnosis of Creutzfeldt-Jakob disease by western blot identification of marker protein in human brain tissue. N Engl J Med 1986;314:547-51
   PubMed Web of Science ®Google Scholar
• Lee DC, Stenland CJ, Hartwell RC, Monitoring plasma processing steps with a sensitive western blot assay for the detection of the prion protein. J Virol Methods 2000;84:77-89
   PubMed Web of Science ®Google Scholar
• Madec JY, Groschup MH, Buschmann A, Sensitivity of the western blot detection of prion protein PrPres in natural sheep scrapie. J Virol Methods 1998;75:169-77
   PubMed Web of Science ®Google Scholar
• Grassi J, Creminon C, Frobert Y, Specific determination of the proteinase K-resistant form of the prion protein using two-site immunometric assays. Application to the post-mortem diagnosis of BSE. Arch Virol Suppl 2000;16:197-205
   Google Scholar
• Lee IS, Long JR, Prusiner SB, Safar JG. Selective precipitation of prions by polyoxometalate complexes. J Am Chem Soc 2005;127:13802-3
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Joiner S, Hill AF, Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80
   PubMed Web of Science ®Google Scholar
• Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;349:1812-20
   PubMed Web of Science ®Google Scholar
• Notari S, Moleres FJ, Hunter SB, Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One 2010;5:e8765
   PubMed Web of Science ®Google Scholar
• Peden AH, Ritchie DL, Head MW, Ironside JW. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006;168:927-35
   PubMed Web of Science ®Google Scholar
• Fischer MB, Roeckl C, Parizek P, Binding of disease-associated prion protein to plasminogen. Nature 2000;408:479-83
   PubMed Web of Science ®Google Scholar
• Shaked Y, Engelstein R, Gabizon R. The binding of prion proteins to serum components is affected by detergent extraction conditions. J Neurochem 2002;82:1-5
   PubMed Web of Science ®Google Scholar
• Rhie A, Kirby L, Sayer N, Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem 2003;278:39697-705
   PubMed Web of Science ®Google Scholar
• Moussa A, Coleman AW, Bencsik A, Use of streptomycin for precipitation and detection of proteinase K resistant prion protein (PrPsc) in biological samples. Chem Commun (Camb) 2006;9:973-5
   PubMedGoogle Scholar
• Quadrio I, Ugnon-Cafe S, Dupin M, Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues. Lab Invest 2009;89:406-13
   PubMed Web of Science ®Google Scholar
• Lane A, Stanley CJ, Dealler S, Wilson SM. Polymeric ligands with specificity for aggregated prion proteins. Clin Chem 2003;49:1774-5
   Web of Science ®Google Scholar
• Pastrana MA, Sajnani G, Onisko B, Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006;45:15710-17
   PubMed Web of Science ®Google Scholar
• Cronier S, Gros N, Tattum MH, Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008;416:297-305
   Google Scholar
• Owen JP, Maddison BC, Whitelam GC, Gough KC. Use of thermolysin in the diagnosis of prion diseases. Mol Biotechnol 2007;35:161-70
   Google Scholar
• Bastian FO, McDermott ME, Perry AS, Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease. J Virol Methods 2005;130:133-9
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Prokop S, Jung HH, Atypical prion protein conformation in familial prion disease with PRNP P105T mutation. Brain Pathol 2011;21:209-14
   PubMed Web of Science ®Google Scholar
• Curin Serbec V, Bresjanac M, Popovic M, Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue. J Biol Chem 2004;279:3694-8
   PubMed Web of Science ®Google Scholar
• Jones M, Wight D, McLoughlin V, An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP(Sc)) from human brain specimens. Brain Pathol 2009;19:293-302
   PubMed Web of Science ®Google Scholar
• Korth C, Stierli B, Streit P, Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997;390:74-7
   PubMed Web of Science ®Google Scholar
• Paramithiotis E, Pinard M, Lawton T, A prion protein epitope selective for the pathologically misfolded conformation. Nat Med 2003;9:893-9
   PubMed Web of Science ®Google Scholar
• Tattum MH, Jones S, Pal S, A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K. Transfusion 2010;50:2619-27
   PubMed Web of Science ®Google Scholar
• Safar JG, Geschwind MD, Deering C, Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005;102:3501-6
   PubMed Web of Science ®Google Scholar
• Safar JG, Lessard P, Tamguney G, Transmission and detection of prions in feces. J Infect Dis 2008;198:81-9
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Head MW, Hegyi I, Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 2002;12:1-11
   Google Scholar
• Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000;156:51-6
   PubMed Web of Science ®Google Scholar
• Will RG, Ward HJ. Clinical features of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004;284:121-32
   PubMed Web of Science ®Google Scholar
• Ghetti B, Dlouhy SR, Giaccone G, Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol 1995;5:61-75
   PubMed Web of Science ®Google Scholar
• Tschampa HJ, Zerr I, Urbach H. Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 2007;17:1200-11
   PubMed Web of Science ®Google Scholar
• Meissner B, Kallenberg K, Sanchez-Juan P, MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 2009;72:1994-2001
   PubMed Web of Science ®Google Scholar
• Zerr I, Kallenberg K, Summers DM, Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132:2659-68
   PubMed Web of Science ®Google Scholar
• Collie DA, Summers DM, Sellar RJ, Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003;24:1560-9
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Horvath S, Strobel T, Genetic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2009;80:1410-11
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Doh-ura K, Kudo Y, Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. J Gen Virol 2004;85:1785-90
   PubMed Web of Science ®Google Scholar
• Kepe V, Ghetti B, Farlow MR, PET of brain prion protein amyloid in Gerstmann-Straussler-Scheinker disease. Brain Pathol 2010;20:419-30
   PubMed Web of Science ®Google Scholar
• Hsich G, Kenney K, Gibbs CJ, The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-30
   PubMed Web of Science ®Google Scholar
• Chohan G, Pennington C, Mackenzie JM, The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010;81:1243-8
   PubMed Web of Science ®Google Scholar
• Bahl JM, Heegaard NH, Falkenhorst G, The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol Aging 2009;30:1834-41
   PubMed Web of Science ®Google Scholar
• Sanchez-Juan P, Green A, Ladogana A, CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67:637-43
   PubMed Web of Science ®Google Scholar
• Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001;56:1528-33
   PubMed Web of Science ®Google Scholar
• Sanchez-Juan P, Sanchez-Valle R, Green A, Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 2007;254:901-6
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Puopolo M, Ladogana A, Genetic prion disease: the EUROCJD experience. Hum Genet 2005;118:166-74
   PubMed Web of Science ®Google Scholar
• Ladogana A, Sanchez-Juan P, Mitrova E, Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 2009;256:1620-8
   PubMed Web of Science ®Google Scholar
• Brown P, Preece M, Brandel JP, Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81
   PubMed Web of Science ®Google Scholar
• Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology 2007;69:360-7
   PubMed Web of Science ®Google Scholar
• Green AJ, Ramljak S, Muller WE, 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Neurosci Lett 2002;324:57-60
   PubMed Web of Science ®Google Scholar
• Steinacker P, Rist W, Swiatek-de-Lange M, Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics 2010;10:81-9
   PubMed Web of Science ®Google Scholar
• Tagliavini F, Prelli F, Porro M, A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun 1992;184:1398-404
   PubMed Web of Science ®Google Scholar
• Bieschke J, Giese A, Schulz-Schaeffer W, Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA 2000;97:5468-73
   PubMed Web of Science ®Google Scholar
• Meyne F, Gloeckner SF, Ciesielczyk B, Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 2009;17:863-73
   PubMed Web of Science ®Google Scholar
• Schmitz M, Schlomm M, Hasan B, Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease. Eur J Neurosci 2010;31:2024-31
   PubMed Web of Science ®Google Scholar
• Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Three reported cases of variant Creutzfeldt-Jakob disease transmission following transfusion of labile blood components. Vox Sang 2006;91:348
   Google Scholar
• HPA. Fourth case of variant CJD infection associated with blood transfusion. [Press release] 2007 2007 01 17 [cited January 2007]; Available from: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/CreutzfeldtJakobDisease/VariantCJDAndBlood/ [Last accessed May 5, 2011]
   Google Scholar
• Llewelyn CA, Hewitt PE, Knight RS, Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21
   PubMed Web of Science ®Google Scholar
• Peden AH, Head MW, Ritchie DL, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9
   PubMed Web of Science ®Google Scholar
• Wroe SJ, Pal S, Siddique D, Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061-7
   PubMed Web of Science ®Google Scholar
• Guntz P, Walter C, Schosseler P, Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples. Transfusion 2010;50:989-95
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001;411:810-13
   PubMed Web of Science ®Google Scholar
• Castilla J, Saa P, Soto C. Detection of prions in blood. Nat Med 2005;11:982-5
   PubMed Web of Science ®Google Scholar
• Saa P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006;313:92-4
   PubMed Web of Science ®Google Scholar
• Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 2006;281:35245-52
   PubMed Web of Science ®Google Scholar
• Edgeworth JA, Farmer M, Sicilia A, Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011;377:487-93
   PubMed Web of Science ®Google Scholar
• Shaked GM, Shaked Y, Kariv-Inbal Z, A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem 2001;276:31479-82
   PubMed Web of Science ®Google Scholar
• Furukawa H, Doh-ura K, Okuwaki R, A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins. J Biol Chem 2004;279:23661-7
   PubMed Web of Science ®Google Scholar
• Serban A, Legname G, Hansen K, Immunoglobulins in urine of hamsters with scrapie. J Biol Chem 2004;279:48817-20
   PubMed Web of Science ®Google Scholar
• Gregori L, Kovacs GG, Alexeeva I, Excretion of transmissible spongiform encephalopathy infectivity in urine. Emerg Infect Dis 2008;14:1406-12
   PubMed Web of Science ®Google Scholar
• Seeger H, Heikenwalder M, Zeller N, Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 2005;310:324-6
   PubMed Web of Science ®Google Scholar
• Gonzalez-Romero D, Barria MA, Leon P, Detection of infectious prions in urine. FEBS Lett 2008;582:3161-6
   PubMed Web of Science ®Google Scholar
• Dagdanova A, Ilchenko S, Notari S, Characterization of the prion protein in human urine. J Biol Chem 2010;285:30489-95
   PubMed Web of Science ®Google Scholar
• Capellari S, Strammiello R, Saverioni D, Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 2011;121:21-37
   PubMed Web of Science ®Google Scholar
• Parchi P, Strammiello R, Giese A, Kretzschmar H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol 2011;121:91-112
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) Tables on tissue infectivity distribution in transmissible spongiform encephalopathies, updated 2010. www.who.int/bloodproducts/tablestissueinfectivity.pdf [Last accessed May 5, 2011]
   Google Scholar
• Hill AF, Butterworth RJ, Joiner S, Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9
   PubMed Web of Science ®Google Scholar
• Hilton DA, Ghani AC, Conyers L, Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-9
   PubMed Web of Science ®Google Scholar
• Tabaton M, Monaco S, Cordone MP, Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann Neurol 2004;55:294-6
   PubMed Web of Science ®Google Scholar
• Zanusso G, Ferrari S, Cardone F, Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;348:711-19
   PubMed Web of Science ®Google Scholar
• Krasemann S, Neumann M, Geissen M, Preclinical deposition of athological prion protein in muscle of experimentally infected primates. PLoS One 2010;5:e13906
   PubMedGoogle Scholar
• Favereaux A, Quadrio I, Perret-Liaudet A, Prion protein accumulation involving the peripheral nervous system in a sporadic case of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2003;29:602-5
   PubMed Web of Science ®Google Scholar
• Favereaux A, Quadrio I, Vital C, Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease. Arch Neurol 2004;61:747-50
   PubMed Web of Science ®Google Scholar
• Pocchiari M, Puopolo M, Croes EA, Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004;127:2348-59
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Budka H. Distribution of apoptosis-related proteins in sporadic Creutzfeldt-Jakob disease. Brain Res 2010;1323:192-9
   PubMed Web of Science ®Google Scholar
• Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 2010;107:12005-10
   PubMed Web of Science ®Google Scholar
• Jones M, Peden AH, Wight D, Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport 2008;19:1783-6
   PubMed Web of Science ®Google Scholar
• Parchi P, Cescatti M, Notari S, Agent strain variation in human prion disease: insights from a molecular and pathological review of the national institutes of health series of experimentally transmitted disease. Brain 2010;133:3030-42
   PubMed Web of Science ®Google Scholar
• Yuan J, Xiao X, McGeehan J, Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem 2006;281:34848-58
   PubMed Web of Science ®Google Scholar
• Arsac JN, Biacabe AG, Nicollo J, Biochemical identification of bovine spongiform encephalopathies in cattle. Acta Neuropathol 2007;114:509-16
   PubMed Web of Science ®Google Scholar
• Casalone C, Zanusso G, Acutis P, Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 2004;101:3065-70
   PubMed Web of Science ®Google Scholar
• Comoy EE, Casalone C, Lescoutra-Etchegaray N, Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS One 2008;3:e3017
   PubMed Web of Science ®Google Scholar
• Kong Q, Zheng M, Casalone C, Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol 2008;82:3697-701
   PubMed Web of Science ®Google Scholar
• Clewley JP, Kelly CM, Andrews N, Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009;338:b1442
   PubMed Web of Science ®Google Scholar
• Brown P. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy. Vox Sang 2005;89:63-70
   PubMed Web of Science ®Google Scholar
• Brown P, Cervenakova L, Diringer H. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001;137:5-13
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Botond G, Budka H. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol 2010;119:389-408
   PubMed Web of Science ®Google Scholar
• Head MW, Lowrie S, Chohan G, Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, alpha synuclein and Abeta pathology. Acta Neuropathol 2010;120:821-3
   PubMed Web of Science ®Google Scholar
• Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010;33:317-25
   PubMed Web of Science ®Google Scholar
• Petkova AT, Leapman RD, Guo Z, Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 2005;307:262-5
   PubMed Web of Science ®Google Scholar
• Collins SJ, Sanchez-Juan P, Masters CL, Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006;129:2278-87
   PubMed Web of Science ®Google Scholar
• Castellani RJ, Colucci M, Xie Z, Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004;63:436-42
   PubMed Web of Science ®Google Scholar
• Zerr I, Pocchiari M, Collins S, Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-15
   PubMed Web of Science ®Google Scholar
• Otto M, Wiltfang J, Cepek L, Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002;58:192-7
   PubMed Web of Science ®Google Scholar
• Van Everbroeck B, Quoilin S, Boons J, A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2003;74:1210-14
   PubMed Web of Science ®Google Scholar
• Riemenschneider M, Wagenpfeil S, Vanderstichele H, Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 2003;8:343-7
   PubMed Web of Science ®Google Scholar
• Goodall CA, Head MW, Everington D, Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry 2006;77:89-91
   PubMed Web of Science ®Google Scholar
• Skinningsrud A, Stenset V, Gundersen AS, Fladby T. Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res 2008;5:14
   PubMedGoogle Scholar
• Satoh K, Shirabe S, Eguchi H, 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 2006;26:45-52
   PubMed Web of Science ®Google Scholar
• Baldeiras IE, Ribeiro MH, Pacheco P, Diagnostic value of CSF protein profile in a portuguese population of sCJD patients. J Neurol 2009;256:1540-50
   PubMed Web of Science ®Google Scholar
• Meiner Z, Kahana E, Baitcher F, Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol 2010;258:255-62
   PubMed Web of Science ®Google Scholar
• Wang GR, Gao C, Shi Q, Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease. Am J Med Sci 2010;340:291-5
   PubMed Web of Science ®Google Scholar